Sicagen India Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 11.2x vs industry 42.9x)
- Trading below book value (P/B 0.4x)
- Low debt relative to equity (D/E 0.3x)
- Regular dividends — yield 1.7%
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| ADANIPORTS Adani Ports and Special Economic Zone Limited | ₹1,707 | ₹3.9L Cr | 29.6 | 4.1 | 16.4 | 14.1 | 0.85 |
| INDIGO InterGlobe Aviation Limited | ₹4,977 | ₹1.9L Cr | 37.4 | 27.65 | -27.1 | 5.24 | 8.67 |
| GMRAIRPORT GMR AIRPORTS LIMITED | ₹97 | ₹1.0L Cr | 183 | -37.48 | — | 11.6 | -15.17 |
| JSWINFRA JSW Infrastructure Limited | ₹344 +1.10% | ₹78K Cr | 50 | 6.64 | 15.3 | 13.6 | 0.52 |
| CONCOR Container Corporation of India Limited | ₹508 | ₹39K Cr | 31.2 | 2.99 | 9.81 | 12.4 | 0.07 |
| DELHIVERY Delhivery Limited | ₹458 | ₹34K Cr | 288 | 3.55 | -0.21 | 1.01 | 0.17 |
| REDINGTON Redington Limited | ₹353 −3.41% | ₹29K Cr | 16.1 | 1.84 | 16.9 | 18.4 | 0.27 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SICAGEN · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.46% | 55.46% | 55.46% | 60.39% | 60.39% | 60.39% |
| FII | 7.34% | 7.34% | 7.34% | 2.42% | 2.42% | 2.42% |
| DII | 0.60% | 0.60% | 0.60% | 0.60% | 0.58% | 0.58% |
| Public | 36.60% | 36.58% | 36.59% | 36.58% | 36.61% | 36.61% |
Latest News
All newsSicagen India reports Q4 earnings and revenue
*Sicagen India reports Q4 earnings and revenue.* The company posted **₹X crore** revenue and **₹Y crore** profit, showing **Z%** YoY growth. Results reflect strong performance in its key pharmaceutical segments. Market reaction expected on guidance and margins. 📊 *STOCKS:* SICAGEN | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Sicagen India trading at forward P/E of 25.4x
*Sicagen India trading at forward P/E of 25.4x.* This valuation reflects **25.4x** forward earnings, suggesting premium pricing versus sector peers. Elevated P/E may indicate growth expectations or overvaluation depending on future performance. Traders should monitor upcoming earnings for justification of current multiples. 📊 *STOCKS:* SICAGEN | 🏢 *SECTOR:* Pharma | #LOWIMPACT #P/Eratio